Tong Yunsong, Stewart Kent D, Thomas Sheela, Przytulinska Magdalena, Johnson Eric F, Klinghofer Vered, Leverson Joel, McCall Owen, Soni Niru B, Luo Yan, Lin Nan-horng, Sowin Thomas J, Giranda Vincent L, Penning Thomas D
Cancer Research, Global Pharmaceutical R&D, Abbott Laboratories, R47S, AP10, 100 Abbott Park Road, Abbott Park, IL 60064, USA.
Bioorg Med Chem Lett. 2008 Oct 1;18(19):5206-8. doi: 10.1016/j.bmcl.2008.08.079. Epub 2008 Aug 28.
A series of isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones were synthesized as potent inhibitors against Pim-1 and Pim-2 kinases. The structure-activity-relationship studies started from a high-throughput screening hit and was guided by molecular modeling of inhibitors in the active site of Pim-1 kinase. Installing a hydroxyl group on the benzene ring of the core has the potential to form a key hydrogen bond interaction to the hinge region of the binding pocket and thus resulted in the most potent inhibitor, 19, with K(i) values at 2.5 and 43.5 nM against Pim-1 and Pim-2, respectively. Compound 19 also exhibited an activity profile with a high degree of kinase selectivity.
合成了一系列异恶唑并[3,4 - b]喹啉 - 3,4(1H,9H) - 二酮作为针对Pim - 1和Pim - 2激酶的强效抑制剂。构效关系研究从高通量筛选命中物开始,并以Pim - 1激酶活性位点中抑制剂的分子模型为指导。在核心苯环上引入一个羟基有可能与结合口袋的铰链区形成关键的氢键相互作用,从而产生了最有效的抑制剂19,其对Pim - 1和Pim - 2的K(i)值分别为2.5和43.5 nM。化合物19还表现出高度的激酶选择性活性谱。